144 related articles for article (PubMed ID: 29332170)
21. A combination of mRNA expression profile and miRNA expression profile identifies detection biomarkers in different tumor stages of laryngeal squamous cell carcinoma.
Yu CH; Xing FY; Zhang JY; Xu JQ; Li YC
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7296-7304. PubMed ID: 30468474
[TBL] [Abstract][Full Text] [Related]
22. Aberrant expressed long non-coding RNAs in laryngeal squamous-cell carcinoma.
Li H; Wang FL; Li W; Fei YH; Wang YT; Zhang JE; Bi HY; Zhang M
Am J Otolaryngol; 2019; 40(5):615-625. PubMed ID: 31128861
[TBL] [Abstract][Full Text] [Related]
23. Integrative analysis of mRNA and microRNA expression profiles in laryngeal squamous cell carcinoma.
Ekmekci CG; Coskunpinar E; Avci H; Farooqi AA; Orhan KS; Akbas F
J Cell Biochem; 2019 Mar; 120(3):3415-3422. PubMed ID: 30362598
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA‑195 inhibits cell proliferation, migration and invasion in laryngeal squamous cell carcinoma by targeting ROCK1.
Liu Y; Liu J; Wang L; Yang X; Liu X
Mol Med Rep; 2017 Nov; 16(5):7154-7162. PubMed ID: 28901478
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.
Li M; Tian L; Ren H; Chen X; Wang Y; Ge J; Wu S; Sun Y; Liu M; Xiao H
J Transl Med; 2015 Aug; 13():271. PubMed ID: 26286725
[TBL] [Abstract][Full Text] [Related]
26. miR-1297 mediates PTEN expression and contributes to cell progression in LSCC.
Li X; Wang HL; Peng X; Zhou HF; Wang X
Biochem Biophys Res Commun; 2012 Oct; 427(2):254-60. PubMed ID: 22995297
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
Zhang T; Liu M; Wang C; Lin C; Sun Y; Jin D
Anticancer Res; 2011 Nov; 31(11):3859-63. PubMed ID: 22110210
[TBL] [Abstract][Full Text] [Related]
28. Aberrant expression of CDK8 regulates the malignant phenotype and associated with poor prognosis in human laryngeal squamous cell carcinoma.
Li M; Zhao X; Liu Y; An J; Xiao H; Wang C
Eur Arch Otorhinolaryngol; 2017 May; 274(5):2205-2213. PubMed ID: 28220308
[TBL] [Abstract][Full Text] [Related]
29. Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma.
Gao X; Wang Y; Zhao H; Wei F; Zhang X; Su Y; Wang C; Li H; Ren X
Oncotarget; 2016 Sep; 7(37):59664-59675. PubMed ID: 27517633
[TBL] [Abstract][Full Text] [Related]
30. [DNA microarrays-based microRNA expression profiles derived from formalin-fixed paraffin-embedded tissue blocks of squammous cell carcinoma of larynx].
Li L; Zhang ZM; Liu Y; Wei MH; Xue LY; Zou SM; Di XB; Han NJ; Zhang KT; Xu ZG; Gao YN
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):391-5. PubMed ID: 21055156
[TBL] [Abstract][Full Text] [Related]
31. MiR-613 suppressed the laryngeal squamous cell carcinoma progression through regulating PDK1.
Wang J; Yang S; Ge W; Wang Y; Han C; Li M
J Cell Biochem; 2018 Jul; 119(7):5118-5125. PubMed ID: 29091303
[TBL] [Abstract][Full Text] [Related]
32. miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC).
Yungang W; Xiaoyu L; Pang T; Wenming L; Pan X
Biomed Pharmacother; 2014 Mar; 68(2):149-54. PubMed ID: 24055400
[TBL] [Abstract][Full Text] [Related]
33. Construction of an initial microRNA regulation network in breast invasive carcinoma by bioinformatics analysis.
Yin Y; Shen C; Xie P; Cheng Z; Zhu Q
Breast; 2016 Apr; 26():1-10. PubMed ID: 27017236
[TBL] [Abstract][Full Text] [Related]
34. [The effect of miR-497 on laryngeal squamous cell carcinoma invasion through modulating PlexinA4].
Niu JT; Liu SG; Huang YW; Li C
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):124-130. PubMed ID: 29429182
[No Abstract] [Full Text] [Related]
35. Establishment and characterization of a novel HPV-negative laryngeal squamous cell carcinoma cell line, FD-LSC-1, with missense and nonsense mutations of TP53 in the DNA-binding domain.
Wu CP; Zhou L; Gong HL; Du HD; Tian J; Sun S; Li JY
Cancer Lett; 2014 Jan; 342(1):92-103. PubMed ID: 24001612
[TBL] [Abstract][Full Text] [Related]
36. [Mechanism research progress of miRNA in laryngeal carcinoma].
Peng YH; Yang WF; Lu SW; Lan XB; Peng SP
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jul; 31(14):1134-1139. PubMed ID: 29798260
[TBL] [Abstract][Full Text] [Related]
37. [MicroRNAs regulate epithelial-mesenchymal transition of supraglottic laryngeal cancer].
Tai J; Xiao X; Huang ZG; Yu ZK; Chen XH; Zhou WG; Chen XJ; Rao YS; Fang JG; Ni X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jun; 48(6):499-503. PubMed ID: 24103175
[TBL] [Abstract][Full Text] [Related]
38. Dysregulated microRNAs in laryngeal cancer: a comprehensive meta-analysis using a robust rank aggregation approach.
Cao Z; Guo Y; Ao Y; Zhou S
Future Oncol; 2020 Nov; 16(33):2723-2734. PubMed ID: 32812475
[TBL] [Abstract][Full Text] [Related]
39. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
40. Screening for MiRNAs related to laryngeal squamous carcinoma stem cell radiation.
Huang CX; Zhu Y; Duan GL; Yao JF; Li ZY; Li D; Wang QQ
Asian Pac J Cancer Prev; 2013; 14(8):4533-7. PubMed ID: 24083697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]